BM32: Ph IIb data

Top-line data from 124 evaluable grass pollen-allergic patients in a double-blind, Austrian Phase IIb trial showed that once-monthly 80

Read the full 190 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE